These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 8796141

  • 41. Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport.
    Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson RV.
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1433-8. PubMed ID: 8388880
    [Abstract] [Full Text] [Related]

  • 42. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
    Buyalos RP, Jackson RV, Grice GI, Hockings GI, Torpy DJ, Fox LM, Boots LR, Azziz R.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
    [Abstract] [Full Text] [Related]

  • 43. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB, Landman RE, Wardlaw SL, Conwell IM, Freda PU.
    Pituitary; 2005 Sep; 8(2):115-22. PubMed ID: 16379031
    [Abstract] [Full Text] [Related]

  • 44. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
    Scott LV, Burnett F, Medbak S, Dinan TG.
    Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.
    Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
    [Abstract] [Full Text] [Related]

  • 48. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
    [Abstract] [Full Text] [Related]

  • 49. [Effect of Sini decoction on function of hypothalamic-pituitary-adrenal axis in patients with sepsis].
    Huang R, Zhang Z, Xu M, Chang X, Qiao Q, Wang L, Meng X.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):184-7. PubMed ID: 24598293
    [Abstract] [Full Text] [Related]

  • 50. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone.
    Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ.
    Alcohol Clin Exp Res; 2005 Apr; 29(4):528-37. PubMed ID: 15834217
    [Abstract] [Full Text] [Related]

  • 51. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome.
    Lanzone A, Petraglia F, Fulghesu AM, Ciampelli M, Caruso A, Mancuso S.
    Fertil Steril; 1995 Jun; 63(6):1195-9. PubMed ID: 7750588
    [Abstract] [Full Text] [Related]

  • 52. Comparison of HPA axis hormonal responses to naloxone vs psychologically-induced stress.
    Oswald LM, Mathena JR, Wand GS.
    Psychoneuroendocrinology; 2004 Apr; 29(3):371-88. PubMed ID: 14644067
    [Abstract] [Full Text] [Related]

  • 53. Hypothalamic-pituitary-adrenal axis and ethanol modulation of deoxycorticosterone levels in cynomolgus monkeys.
    Porcu P, Grant KA, Green HL, Rogers LS, Morrow AL.
    Psychopharmacology (Berl); 2006 Jun; 186(3):293-301. PubMed ID: 16133132
    [Abstract] [Full Text] [Related]

  • 54. Association of hypothalamic-pituitary-adrenal axis function with neuropsychological performance in children with mild/moderate asthma.
    Annett RD, Stansbury K, Kelly HW, Strunk RC.
    Child Neuropsychol; 2005 Aug; 11(4):333-48. PubMed ID: 16051562
    [Abstract] [Full Text] [Related]

  • 55. Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome.
    Wortsman J, Wehrenberg WB, Gavin JR, Allen JP.
    Obstet Gynecol; 1984 May; 63(5):630-4. PubMed ID: 6326013
    [Abstract] [Full Text] [Related]

  • 56. Obstructive sleep apnoea syndrome is associated with relative hypocortisolemia and decreased hypothalamo-pituitary-adrenal axis response to 1 and 250μg ACTH and glucagon stimulation tests.
    Karaca Z, Ismailogullari S, Korkmaz S, Cakir I, Aksu M, Baydemir R, Tanriverdi F, Bayram F.
    Sleep Med; 2013 Feb; 14(2):160-4. PubMed ID: 23218531
    [Abstract] [Full Text] [Related]

  • 57. Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
    Maas KH, Chuan S, Harrison E, Cook-Andersen H, Duleba AJ, Chang RJ.
    Fertil Steril; 2016 Oct; 106(5):1252-1257. PubMed ID: 27473350
    [Abstract] [Full Text] [Related]

  • 58. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.
    Kondoh Y, Uemura T, Ishikawa M, Yokoi N, Hirahara F.
    Fertil Steril; 1999 Jul; 72(1):15-20. PubMed ID: 10428142
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.